➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Baxter
Dow
Harvard Business School
Medtronic
Colorcon
Merck

Last Updated: August 10, 2020

DrugPatentWatch Database Preview

Litigation Details for Takeda Pharmaceutical Co., LTD v. Handa Pharmaceuticals, LLC (N.D. Cal. 2011)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Small Molecule Drugs cited in Takeda Pharmaceutical Co., LTD v. Handa Pharmaceuticals, LLC
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .

Details for Takeda Pharmaceutical Co., LTD v. Handa Pharmaceuticals, LLC (N.D. Cal. 2011)

Date Filed Document No. Description Snippet Link To Document
2012-04-11 106 following Takeda patents are at issue in the Actions: 1) U.S. Patent No. 6,462,058 (“the … 14 ’058 Patent”); 2) U.S. Patent No. 6,664,276 (“the ’276 Patent”); 3) U.S. Patent No. 6,939,971… 15 ’971 Patent”); 4) U.S. Patent No. 7,737,282 (“the ’282 Patent”); 5) U.S. Patent No. 7,285,668… 16 ’668 Patent”) and 6) U.S. Patent No. 7,790,755 (“the ’755 Patent”). … pharmaceutical patent, even if it is not in the same patent family as the ’282 patent. Id. at 7-8. External link to document
2011-04-29 30 record and assignee of U.S. Patent No. 6,462,058 (“the ‘058 Patent”), U.S. Patent No. … to be a copy of United States Patent No. 6,462,058 (“the ‘058 Patent”) titled “Benzimidazole 15 Compound…22 (Patent Infringement of U.S. Patent No. 6,462,058) 23 37. Handa… (Declaratory Judgment as to U.S. Patent Nos. 6,462,058, 6,664,576, …infringe 13 any valid claim of United States Patent Nos. 6,462,058, 6,664,276, 6,939,971, 7,285,668, and 14 External link to document
2013-04-30 336 Defendants. PATENT NO. 7,790,755 UNDER FED. R. …for Judgment of Non-Infringement of U.S. Patent No. 7,790,755 Under Fed. R. Civ. P. 4 54(b) (“54(b…' Motion for Judgment of Non-Infringement of US Patent '755 and Exhibit 2.(klhS, COURT STAFF) (Filed on…2011 1 November 2013 3:11-cv-00840-JCS Patent None District Court, N.D. California External link to document
2013-10-17 446 the following patents: 1) U.S. Patent No. 6,462,058 (“the ’058 Patent”); 2) U.S. Patent No. 6,664,276 …crystallinity data reported in two Takeda patents: U.S. Patent No. 6,462,058, which issued from the parent application…6,664,276 (“the ’276 Patent”); 3) U.S. Patent No. 6,939,971 (“the ’971 Patent”); 4) U.S. Patent No. 7,737,282 … (“the ’282 Patent”); 5) U.S. Patent No. 7,285,668 (“the ’668 Patent”) and 6) U.S. Patent No. 7,790,755…TX 0001 (’058 Patent); TX 0002 (’276 Patent); TX 1054 (’971 Patent); TX 1055 (’282 Patent). All have essentially External link to document
2013-11-01 451 of U.S. Patent No. 6,664,276 (“the ’276 11 Patent”) and asserted claims 1 and 2 of U.S. Patent No. 7,737,282…as to Patent No.'276, and '282. Judgment is in favor of Handa/Par against Takeda as to '755 Patent. Signed…asserted claims 2, 4, and 6 of U.S. Patent No. 7,790,755 (“the ’755 Patent”); and it is 21 further, 22 …Page 3 of 4 1 and ’282 Patents (currently, June 15, 2020, for the ’282 Patent, and December 15, 2020,…the’276 Patent, which date is subject to extension 3 pursuant to Takeda’s request for patent term extension External link to document
2013-12-09 467 For Judgment of NonInfringement of U.S. Patent No. 7,790,755 Under Fed. R. Civ. P. 54(B) by Takeda Pharmaceutical…2011 1 November 2013 3:11-cv-00840-JCS Patent None District Court, N.D. California External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Merck
Medtronic
AstraZeneca
Colorcon
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.